Results 161 to 170 of about 13,390,811 (365)

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

open access: yesMolecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton   +17 more
wiley   +1 more source

Maximum Weight Spectrum Codes

open access: yes, 2018
In the recent work \cite{shi18}, a combinatorial problem concerning linear codes over a finite field $\F_q$ was introduced. In that work the authors studied the weight set of an $[n,k]_q$ linear code, that is the set of non-zero distinct Hamming weights,
Alderson, Tim L., Neri, Alessandro
core  

Research progress of residual stress measurement methods

open access: yesHeliyon
Residual stress refers to self-equilibrating stress present within materials, with the potential to significantly affect manufacturing processes and performance.
Xuewen Li   +8 more
doaj  

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

open access: yesMolecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop   +10 more
wiley   +1 more source

Endoscopic removal of a weight-loss device with stoma closure using a tack-and-suture device

open access: yesVideoGIE, 2023
Areebah Waseem, BS   +5 more
doaj  

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

open access: yesMolecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed   +8 more
wiley   +1 more source

Crack inhibition and crystallographic texture control in an additively manufactured IN738LC Ni-based superalloy

open access: yesJournal of Materials Research and Technology
The additive manufacturing of directionally solidified Ni-based superalloys remains a significant challenge due to the formation of stray equiaxed grains and their high susceptibility to cracking, particularly for high-volume γ´-type Ni-based superalloys.
Fangxian Zhang   +5 more
doaj  

Home - About - Disclaimer - Privacy